← All organizations

ImmunoCellular Therapeutics, Ltd.

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 1, 2015

Acquired by EOM Pharmaceuticals on Dec 2, 2021

Timeline

2000s

Jun 1, 2006
ImmunoCellular Therapeutics, Ltd.— Founded

2020s

Dec 2, 2021
EOM Pharmaceuticals— Acquired By

Drugs by trial phase (2 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

ict-107

Phase 1 (1 own, 0 via acquisition)

ict-121 dc vaccine

Indications

Studied for

Glioblastoma

Recent trials (5)

NCT02546102Lead sponsorPhase 3Dec 1, 2015
NCT02049489Study directorPhase 1Dec 1, 2013
NCT02049489Lead sponsorPhase 1Dec 1, 2013
NCT01280552Study directorPhase 2Jan 1, 2011
NCT01280552Lead sponsorPhase 2Jan 1, 2011

Details

Founded: Calabasas, CA, US Jun 1, 2006
Last known activity: Dec 1, 2015